Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cellsStavroula Baritaki, Eriko Suzuki, Kazuo Umezawa, et al.
Forum on Immunopathological Diseases and Therapeutics|November 29, 2013
Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple MyelomaStavroula Baritaki, Sara Huerta-Yepez, Ma da Lourdas Cabrava-Haimandez, et al.
Cancer Biomarkers : Section a of Disease Markers|September 5, 2009
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcomeNam K Yoon, David B Seligson, David Chia, et al.
International Journal of Oncology|June 2, 2010
A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assayHaiming Chen, Cathy S Wang, Mingjie Li, et al.
Plos One|March 25, 2014
Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancerSaad Yousuf, MeiLi Duan, Erika L Moen, et al.
British Journal of Haematology|June 26, 2007
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acidRichard A Campbell, Eric Sanchez, Jeffrey A Steinberg, et al.
BMC Cancer|October 18, 2015
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaGabriel G Vega, Alejandro Avilés-Salas, J Ramón Chalapud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functionsMario I Vega, Sara Huerta-Yepez, Melisa Martinez-Paniagua, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cellsStavroula Baritaki, Eriko Suzuki, Kazuo Umezawa, et al.
Forum on Immunopathological Diseases and Therapeutics|November 29, 2013
Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple MyelomaStavroula Baritaki, Sara Huerta-Yepez, Ma da Lourdas Cabrava-Haimandez, et al.
Cancer Biomarkers : Section a of Disease Markers|September 5, 2009
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcomeNam K Yoon, David B Seligson, David Chia, et al.
International Journal of Oncology|June 2, 2010
A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assayHaiming Chen, Cathy S Wang, Mingjie Li, et al.
Plos One|March 25, 2014
Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancerSaad Yousuf, MeiLi Duan, Erika L Moen, et al.
British Journal of Haematology|June 26, 2007
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acidRichard A Campbell, Eric Sanchez, Jeffrey A Steinberg, et al.
BMC Cancer|October 18, 2015
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaGabriel G Vega, Alejandro Avilés-Salas, J Ramón Chalapud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functionsMario I Vega, Sara Huerta-Yepez, Melisa Martinez-Paniagua, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
BMC Cancer|June 22, 2011
Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survivalSara Huerta-Yepez, Nam K Yoon, Angeles Hernandez-Cueto, et al.
Pageof 20